Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Munenori Hiromura"'
Autor:
Nobuaki Takehana, Tomoyasu Fukui, Yusaku Mori, Munenori Hiromura, Michishige Terasaki, Makoto Ohara, Michiya Takada, Masako Tomoyasu, Yoshihisa Ito, Tetsuro Kobayashi, Sho‐ichi Yamagishi
Publikováno v:
Journal of Diabetes Investigation, Vol 14, Iss 7, Pp 856-863 (2023)
Abstract Aims/Introduction This study aimed to compare the positivity rates of glutamic acid decarboxylase autoantibodies (GADA) and ElisaRSR™ 3 Screen ICA™ (3 Screen ICA), a newly developed assay for the simultaneous measurement of GADA, insulin
Externí odkaz:
https://doaj.org/article/ccf155f05aba41eeaa310a9ea7bbecf1
Autor:
Naoya Osaka, Yusaku Mori, Michishige Terasaki, Munenori Hiromura, Tomomi Saito, Hironori Yashima, Yoshie Shiraga, Raichi Kawakami, Makoto Ohara, Tomoyasu Fukui, Sho-ichi Yamagishi
Publikováno v:
Journal of International Medical Research, Vol 50 (2022)
Objective Sodium-glucose cotransporter-2 (SGLT2) inhibitors exhibit cardioprotective properties in patients with diabetes. However, SGLT2 is not expressed in the heart, and the underlying molecular mechanisms are not fully understood. We investigated
Externí odkaz:
https://doaj.org/article/70384bedcd3a41af9453288197520c36
Autor:
Ayako Fukase, Tomoyasu Fukui, Hiroto Sasamori, Munenori Hiromura, Michishige Terasaki, Yusaku Mori, Toshiyuki Hayashi, Takeshi Yamamoto, Makoto Ohara, Satoshi Goto, Hiroe Nagaike, Tsutomu Hirano, Sho‐ichi Yamagishi
Publikováno v:
Journal of Diabetes Investigation, Vol 11, Iss 5, Pp 1188-1196 (2020)
Abstract Aims To clarify the clinical impact of pancreatic fat volume on beta cell function in type 2 diabetes patients. Materials and Methods One hundred thirty two consecutive type 2 diabetic patients (mean age, 63.7 years) were enrolled in this cr
Externí odkaz:
https://doaj.org/article/16d5dea8472c47619dd4ffbde3de9f32
Autor:
Yusaku Mori, Michishige Terasaki, Munenori Hiromura, Tomomi Saito, Hideki Kushima, Masakazu Koshibu, Naoya Osaka, Makoto Ohara, Tomoyasu Fukui, Hirokazu Ohtaki, Hirano Tsutomu, Sho-ichi Yamagishi
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-9 (2019)
Abstract Background Excess fat deposition could induce phenotypic changes of perivascular adipose tissue (PVAT remodeling), which may promote the progression of atherosclerosis via modulation of adipocytokine secretion. However, it remains unclear wh
Externí odkaz:
https://doaj.org/article/34d39adfe63b4b768cdb679bcb87eac5
Autor:
Yusaku Mori, Hiroyuki Shimizu, Hideki Kushima, Tomomi Saito, Munenori Hiromura, Michishige Terasaki, Masakazu Koshibu, Hirokazu Ohtaki, Tsutomu Hirano
Publikováno v:
Endocrine Connections, Vol 8, Iss 5, Pp 536-546 (2019)
Nesfatin-1 is a novel anorexic peptide hormone that also exerts cardiovascular protective effects in rodent models. However, nesfatin-1 treatment at high doses also exerts vasopressor effects, which potentially limits its therapeutic application. Her
Externí odkaz:
https://doaj.org/article/deafa733658c4ee793c6c92b20045a44
Autor:
Makoto Ohara, Yo Kohata, Hiroe Nagaike, Masakazu Koshibu, Hiroya Gima, Munenori Hiromura, Takeshi Yamamoto, Yusaku Mori, Toshiyuki Hayashi, Tomoyasu Fukui, Tsutomu Hirano
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 11, Iss 1, Pp 1-10 (2019)
Abstract Background The present study evaluated the effects of glucose and blood pressure (BP) variability on oxidative stress in patients with type 2 diabetes mellitus (T2DM) and hypertension. Methods A total of 60 inpatients with T2DM underwent con
Externí odkaz:
https://doaj.org/article/cd3579dfc1a7490081499dd42a86a677
Autor:
Yusaku Mori, Munenori Hiromura, Michishige Terasaki, Hideki Kushima, Makoto Ohara, Tomoyasu Fukui, Yasuyoshi Takahashi, Sho-ichi Yamagishi
Publikováno v:
Journal of International Medical Research, Vol 49 (2021)
Background Methimazole (MMI) is used to treat hyperthyroidism in Graves’ disease. It is rare to encounter patients in whom hyperthyroidism cannot be controlled using high doses of MMI. Case presentation: A 21-year-old woman was referred to our hosp
Externí odkaz:
https://doaj.org/article/cab17121e7ac47a7b964d7146f907519
Autor:
Hideki Kushima, Yusaku Mori, Masakazu Koshibu, Munenori Hiromura, Kyoko Kohashi, Michishige Terasaki, Tomoyasu Fukui, Tsutomu Hirano
Publikováno v:
Cardiovascular Diabetology, Vol 16, Iss 1, Pp 1-17 (2017)
Abstract Background Previous animal studies have shown that glucagon-like peptide-1 receptor agonists (GLP-1RAs) suppress arterial restenosis, a major complication of angioplasty, presumably through their direct action on vascular smooth muscle cells
Externí odkaz:
https://doaj.org/article/acd2b0f06b7943c08611a98b069b169d
Autor:
Hironori Yashima, Michishige Terasaki, Ami Sotokawauchi, Takanori Matsui, Yusaku Mori, Tomomi Saito, Naoya Osaka, Hideki Kushima, Munenori Hiromura, Makoto Ohara, Tomoyasu Fukui, Sho-ichi Yamagishi
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 23, p 9263 (2020)
Advanced glycation end products (AGEs) are localized in macrophage-derived foam cells within atherosclerotic lesions, which could be associated with the increased risk of atherosclerotic cardiovascular disease under diabetic conditions. Although foam
Externí odkaz:
https://doaj.org/article/0aa9afc65a324aacb66d987d94480a8f
Autor:
Michishige Terasaki, Hironori Yashima, Yusaku Mori, Tomomi Saito, Takanori Matsui, Munenori Hiromura, Hideki Kushima, Naoya Osaka, Makoto Ohara, Tomoyasu Fukui, Tsutomu Hirano, Sho-ichi Yamagishi
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 13, p 4811 (2020)
Dipeptidyl peptidase-4 (DPP-4) inhibitors have been reported to play a protective role against atherosclerosis in both animal models and patients with type 2 diabetes (T2D). However, since T2D is associated with dyslipidemia, hypertension and insulin
Externí odkaz:
https://doaj.org/article/9e285243ee544ee1913dac6d90edfce8